David Ricks, Eli Lilly CEO (Sean Krajacic/The Kenosha News via AP)
May 1, 2025 07:23 AM EDTUpdated 08:57 AM
Pharma

Lil­ly meets sales ex­pec­ta­tions, but No­vo gains on PBM win

Kyle LaHucik

Senior Reporter

The weight loss race be­tween Eli Lil­ly and No­vo Nordisk is heat­ing up.

On Thurs­day morn­ing, Eli Lil­ly post­ed $12.73 bil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

US drug­mak­ers in­creas­ing­ly look abroad for clin­i­cal tri­als as con­fi­dence in FDA wa­vers

Af­ter hunt for al­ter­na­tives, Kro­nos Bio se­lects Tang Cap­i­tal's Con­cen­tra for a deal

Ex­clu­sive: Ex-Cal­i­co sci­en­tist launch­es State­ly Bio with new way to study cells

Arv­inas ends plans for two Phase 3 breast can­cer tri­als; Phath­om makes cuts

Ex­its con­tin­ue at FDA, as more staff in drug of­fice fol­low fired col­leagues out the door

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times